Literature DB >> 7534229

Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions.

T Erpel1, G Superti-Furga, S A Courtneidge.   

Abstract

The protein tyrosine kinase c-Src is negatively regulated by phosphorylation of Tyr527 in its C-terminal tail. The repressed state is achieved through intramolecular interactions involving the phosphorylated tail, the Src homology 2 (SH2) domain and the SH3 domain. Both the SH2 and SH3 domains have also been shown to mediate the intermolecular interaction of Src with several proteins. To test which amino acids of the Src SH3 domain are important for these interactions, and whether the intra- and intermolecular associations involve the same residues, we carried out a detailed mutational analysis of the presumptive interaction surface. All mutations of conserved hydrophobic residues had an effect on both inter- and intramolecular interactions of the Src SH3 domain, although not all amino acids were equally important. Chimeric molecules in which the Src SH3 domain was replaced with those of spectrin or Lck showed derepressed kinase activity, whereas a chimera containing the Fyn SH3 domain was fully regulated. Since spectrin and Lck SH3 domains share the conserved hydrophobic residues characteristic of SH3 domains, other amino acids must be important for specificity. Mutational analysis of non- or semi-conserved residues in the RT and n-Src loops showed that some of these were also involved in inter- and intramolecular interactions. Stable transfection of selected SH3 domain mutants into NIH-3T3 cells showed that despite elevated levels of phosphotyrosine, the cells were morphologically normal, indicating that the SH3 domain was required for efficient transformation of NIH-3T3 cells by Src.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534229      PMCID: PMC398168          DOI: 10.1002/j.1460-2075.1995.tb07077.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  72 in total

1.  Solution structure of the SH3 domain of Src and identification of its ligand-binding site.

Authors:  H Yu; M K Rosen; T B Shin; C Seidel-Dugan; J S Brugge; S L Schreiber
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

2.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).

Authors:  J Partanen; E Armstrong; M Bergman; T P Mäkelä; H Hirvonen; K Huebner; K Alitalo
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

4.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

5.  Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.

Authors:  M E Noble; A Musacchio; M Saraste; S A Courtneidge; R K Wierenga
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

6.  The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.

Authors:  L B Vogel; D J Fujita
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  The complete sequence of Drosophila alpha-spectrin: conservation of structural domains between alpha-spectrins and alpha-actinin.

Authors:  R R Dubreuil; T J Byers; A L Sillman; D Bar-Zvi; L S Goldstein; D Branton
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

8.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

9.  The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop.

Authors:  T V Borchert; M Mathieu; J P Zeelen; S A Courtneidge; R K Wierenga
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.

Authors:  M Koegl; R M Kypta; M Bergman; K Alitalo; S A Courtneidge
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

View more
  50 in total

1.  Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.

Authors:  H Cheng; J A Rogers; N A Dunham; T E Smithgall
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.

Authors:  V J Fincham; V G Brunton; M C Frame
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.

Authors:  Egle Avizienyte; Valerie J Fincham; Valerie G Brunton; Margaret C Frame
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

4.  Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.

Authors:  Dörte Adolph; Nadine Flach; Katharina Mueller; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

5.  An examination of dynamics crosstalk between SH2 and SH3 domains by hydrogen/deuterium exchange and mass spectrometry.

Authors:  James M Hochrein; Edwina C Lerner; Anthony P Schiavone; Thomas E Smithgall; John R Engen
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

6.  Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells.

Authors:  Karen L Burger; Brian S Learman; Amy K Boucherle; S Joseph Sirintrapun; Scott Isom; Begoña Díaz; Sara A Courtneidge; Darren F Seals
Journal:  Prostate       Date:  2013-10-30       Impact factor: 4.104

7.  Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.

Authors:  C Brignatz; M P Paronetto; S Opi; M Cappellari; S Audebert; V Feuillet; G Bismuth; S Roche; S T Arold; C Sette; Y Collette
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

8.  Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.

Authors:  Raji E Joseph; Thomas E Wales; D Bruce Fulton; John R Engen; Amy H Andreotti
Journal:  Structure       Date:  2017-08-31       Impact factor: 5.006

9.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

10.  The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation.

Authors:  Matthew D Buschman; Paul A Bromann; Pilar Cejudo-Martin; Fang Wen; Ian Pass; Sara A Courtneidge
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.